Cariprazine hydrochloride (Chengdu Kanghong Pharmaceutical)

卡利拉嗪盐酸盐 (成都康弘药业集团股份有限公司)

Report date: 2024/12/25 20:00:50

Base Information

Drug NameCariprazine hydrochloride (Chengdu Kanghong Pharmaceutical)
Drug Alias NameKH-734
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor partial agonistsDopamine D3 receptor partial agonists +[6] 
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorDopamine D3 receptor +[6] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesChengdu Kanghong Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Kanghong Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A